Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that the U.S. Food and Drug Administration (FDA) has approved expanded use of CASGEVY ® (exagamglogene autotemcel) for the treatment ...
Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a ...
Children with sickle cell disease (SCD) had more emergency department (ED) visits if their parents had a greater number of adverse childhood experiences (ACEs) than if their parents had fewer ACEs ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results